FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to narcology, and can be used to predict unstable therapeutic remission in patients with alcoholism. To do this, in patients with alcohol dependence who were admitted to the hospital in a state of withdrawal syndrome, blood is taken after alcohol detoxification and the concentration of the thyroid hormone free thyroxine (T4 fr.) is determined in the blood serum. At its concentration below 10.16 pmol/l, the formation of unstable remission lasting up to 6 months after therapy is predicted.
EFFECT: invention provides an expansion of the arsenal of tools for predicting the duration of therapeutic remission in alcohol dependence.
1 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF DURATION OF THERAPEUTIC REMISSION IN ALCOHOL DEPENDENCE | 2019 |
|
RU2726409C1 |
METHOD FOR PREDICTING THE DURATION OF THERAPEUTIC REMISSION IN PATIENTS WITH ALCOHOLISM | 2021 |
|
RU2756613C1 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2775440C1 |
METHOD FOR PREDICTION OF COMORBID COURSE OF AFFECTIVE DISORDERS AND ALCOHOLISM BASED ON DETERMINATION OF BLOOD SERUM PROTEINS | 2021 |
|
RU2767699C1 |
METHOD FOR TREATMENT OF ALCOHOLIC DELIRIUM | 2005 |
|
RU2289405C2 |
METHOD FOR PREDICTING REMISSION DURATION IN ALCOHOL ADDICTED PATIENTS AT THE REMISSION DEVELOPMENT PERIOD | 2002 |
|
RU2238034C2 |
METHOD OF ALCOHOLIC OR TOBACCO DEPENDENCE TREATMENT OF | 2006 |
|
RU2329027C1 |
METHOD FOR PREDICTION OF RISK OF FORMATION OF ORGANIC ANXIETY DISORDER | 2019 |
|
RU2712915C1 |
AGENT FOR PREVENTION AND TREATMENT OF ALCOHOLISM AND OPIOMANIA | 2008 |
|
RU2393864C1 |
METHOD OF TREATMENT IN ALCOHOLIC DELIRIUM | 2005 |
|
RU2300376C2 |
Authors
Dates
2022-07-22—Published
2021-10-11—Filed